Olympic Champion and “World’s Fittest Human” Invests in PLASMAIDE—An Innovative Blood Health Company

PLASMAIDE announces a strategic investment from Olympic Gold Medalist and Ironman World Champion Kristian Blummenfelt as the company expands its presence to Europe with a new Netherlands distribution hub. The company’s growth includes:

• Established Netherlands distribution center serving EU markets
• Exclusive U.S. distribution partnership with The Feed
• Middle East and Asia expansion scheduled for 2025

Blummenfelt, renowned for breaking the 7-hour Ironman barrier, validated PLASMAIDE‘s effectiveness through extensive personal testing: “feeling how it increased both my oxygen uptake and improved my recovery, I believed that this is a product that will really excel over the next few years, or even months, when more professional athletes have been able to test it out” Blummenfelt stated.

“After talking more to the team, I was then convinced that it’s both a product and a team that I believed in. That’s why I wanted to invest my own money in PLASMAIDE.”

“This investment and expansion represents more than growth—it’s validation from one of endurance sports’ most decorated athletes,” said Steve Allende, PLASMAIDE Co-founder.

PLASMAIDE holds both Informed Sport and firstFlagX certifications—notable in an industry where less than 1% of supplements undergo such testing.

Athletes integrate PLASMAIDE into their routines with a pre-training or competition serving and a post-workout dose for recovery support. The plant-based liquid adaptogen works by optimising blood flow and circulation, directly impacting exercise efficiency and muscle function.

This announcement comes on the heels of PLASMAIDE expanding its global reach by signing an agreement with The Feed to be its exclusive distributor within the United States and is now available in all EU markets, the United Kingdom, The Nordic Region, Australia and New Zealand with a Middle East launch in the next quarter. The company is also about to close a major investment round to power this expansion, signalling strong momentum and investor confidence in PLASMAIDE‘s future.